Peter Jeffrey Gilbar (Peter Gilbar, Peter J Gilbar)

ResearcherID ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 19

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Leukemia & lymphoma

Breast cancer research and treatment

University of Queensland

Flinders University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Queensland

Australia

Senior Lecturer :: Faculty of Medicine (Rural Clinical School)

Toowoomba Health Service Aug 06 1982

Australia

Consultant Pharmacist :: Cancer and Palliative Care Services

Education History

Flinders University

Australia

MSC

University of Queensland

Australia

BSC :: Pharmacy

Publications

Nicole R Pringle, Peter Jeffrey Gilbar, Guranjan D Grewal
Immediate severe hypersensitivity reaction to etoposide phosphate: Case report and review of the literature. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 28 (4) (2022)
Aarya Murali, Philip Wong, Peter Jeffrey Gilbar, Hilda M Mangos
Acquired Hemophilia A following Pfizer-BioNTech SARS CoV-2 mRNA vaccine, successfully treated with prednisolone and rituximab. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 28 (6) (2022)
Peter Jeffrey Gilbar, Marcus Sr Dickey
Case reports of acquired thrombotic thrombocytopenic purpura attributed to pembrolizumab. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
Peter Jeffrey Gilbar, Khageshwor Pokharel
Severe cisplatin-induced renal toxicity in a patient with xeroderma pigmentosum. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Peter Jeffrey Gilbar, Carole R Chambers, Felice Musicco
Preventing drug vial wastage and reducing expenditure associated with injectable cancer drugs: International oncology pharmacy survey. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Bernadatte Zimbwa, Peter Jeffrey Gilbar, Mark R Davis, Srinivas Kondalsamy-Chennakesavan
Retrospective analysis of mortality within 30 days of systemic anticancer therapy and comparison with a previous audit at an Australian Regional Cancer Centre. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Peter Jeffrey Gilbar, Barry R Goldspiel
The continuing importance of oncology case reports. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (2) (2021)
Hannah Van Belle, Sara Alsterlind Hurvitz, Peter Jeffrey Gilbar, Hans P M W Wildiers
Systematic review and meta-analysis of febrile neutropenia risk with TCH(P) in HER2-positive breast cancer. Breast cancer research and treatment 190 (3) (2021)
Peter Jeffrey Gilbar, Mark R Davis
Dosing of PD-1 and PD-L1 inhibitors: Cost saving initiatives for significantly decreasing associated expenditure. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (1) (2020)
Peter Jeffrey Gilbar, Khageshwor Pokharel, Hilda M Mangos
Temozolomide-induced aplastic anaemia: Case report and review of the literature. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (5) (2020)
Peter Jeffrey Gilbar
Vincristine must NEVER be prepared or administered in a syringe. Leukemia & lymphoma 62 (6) (2020)
Anant J Raina, Peter Jeffrey Gilbar, Guranjan D Grewal, David J Holcombe
Optic neuritis induced by 5-fluorouracil chemotherapy: Case report and review of the literature. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (2) (2019)
Marcus Sr Dickey, Anant J Raina, Peter Jeffrey Gilbar, Brendan L Wisniowski, Joel T Collins, Bhaskar Karki, Andrew Dk Nguyen
Pembrolizumab-induced thrombotic thrombocytopenic purpura. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (5) (2019)
Khageshwor Pokharel, Peter Jeffrey Gilbar, Scott K Mansfield, Lekshmi M Nair, Albertina So
Elevated beta human chorionic gonadotropin in a non-pregnant female diagnosed with anal squamous cell carcinoma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (5) (2019)
Peter Jeffrey Gilbar
Inadvertent intrathecal administration of vincristine: Time to finally abolish the syringe. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (2) (2019)
Peter Jeffrey Gilbar, Ian McPherson, Genevieve G Aisthorpe, Srinivas Kondalsamy-Chennakes
Systemic anticancer therapy in the last 30 days of life: Retrospective audit from an Australian Regional Cancer Centre. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 25 (3) (2018)
Peter Jeffrey Gilbar
Shared decision making can aid the informed consent process for end-of-life chemotherapy in cancer patients. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 25 (1) (2018)
Shinya Suzuki, Peter Jeffrey Gilbar, Bo Yu, Chihiro Matsuyama, Masakazu Yamaguchi
Current status of drug vial optimization use to prevent waste associated with injectable anticancer agents. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 25 (1) (2018)
Peter Jeffrey Gilbar, Carole R Chambers, Johan Vandenbrouche, Paul Jm Sessink, Timothy G Tyler
How can the use of closed system transfer devices to facilitate sharing of drug vials be optimised to achieve maximum cost savings? Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 25 (1) (2018)

Peter Jeffrey Gilbar.css-eqlu8i{font-size:small;padding-left:4px;} (Peter Gilbar, Peter J Gilbar)

Publication Activity (10 Years)

Top Topics

Top Venues

Peter Jeffrey Gilbar (Peter Gilbar, Peter J Gilbar)